Special Programs : China Summit 中国高峰会

jun 3, 2019: 2 p.m. - 5:45 p.m.
113ABC, Level 100

China's growing life sciences industries, together with its burgeoning economy, represent one of the most exciting market opportunities for biomedical companies - both for MNCs and start-ups alike. China%u2019s rapidly aging population also means a rising demand for innovative healthcare solutions. However, set against the dynamic backdrop of the U.S.-China bilateral relationship, notably the U.S. CFIUS and Export Control expansion, as well as a transitioning policy environment in China, innovators seeking cross-border partnerships and investment opportunities also face substantial challenges.%uFFFD

The China Summit @ the BIO International Convention will deliver a robust program featuring keynote presentations as well as panel discussions on noteworthy policies and important trends affecting the global biomedical industry in China.%uFFFD

Topics Include:

- Recent policy developments on both sides of the Pacific, including market access and reimbursement of innovative biopharmaceuticals in China, as well as the proposed U.S. investment restrictions.

- Lessons and opportunities in cross-border partnership and financing, including a year one assessment of the HKEX biotech listing rule.

- Silver Lining: An aging China and the implications for healthcare.

The event will be conducted in simultaneous interpretation between English and Chinese.�



Joshua Berlin
Executive Director

JianQing Chang
Vice President, Drug R...

Jeanette Chu
Managing Director

Christian Davis
International Trade Pa...

Ye Li
Vice President of Gove...

Li Yan
Chief Medical Officer

Joseph Damond
Executive Vice Preside...